NEW YORK, Feb. 10, 2014 /PRNewswire/ -- Easton
Pharmaceutical, Inc. (PINKSHEETS: EAPH) is a company that owns,
designs, develops, and markets topically-delivered drugs and
therapeutic / cosmetic healthcare products. Easton Pharmaceuticals
product "VIORRA", is an over-the-counter aid for the treatment to
restore and improve vaginal moisture and elasticity which is
believed to have a positive effect on women's sexual desire and
arousal, FSAD (Female Sexual Arousal Disorder). The world
market demand for this female condition is conservatively estimated
to be in excess of $2 billion. VIORRA
is a topical, daily-use product classified by the FDA as containing
Generally Recognized Safe ingredients.
The potential market for an FASD treatment could rival the
well-known treatment for male erectile dysfunction, Viagra. Viagra,
known generically as sildenafil citrate, hit the market in 1998.
Viagra's manufacturer, Pfizer, increase bottom-line profits by 38
percent for this product alone. In its first year, 2.7 million
prescriptions were filled, and the company posted $411 million in sales, according to reports at
the time. Today, Viagra, is arguably the best selling drug of
all time, and has annual sales of $5
billion and that does not include the plethora of generic
sildenafil citrate being manufactured and sold all over the
world.
Easton's other products
are focused on cancer and other health issues related towards,
wound healing, pain, motion sickness, scar and stretch marks,
cellulite, varicose veins and other conditions. The company's gel
formulation is thought to be an innovative and unique transdermal
delivery system.
EAPH has announced progress toward a product launch date for
VIORRA in Mexico. In other new
development, Easton Pharmaceuticals has executed and closed on an
agreement regarding its Medical Marijuana Initiatives. Another
formal announcement is expected within a few days as well as
possible other HEMP related OTC products Easton has been formulating.
Get the latest information on the VIORRA and marijuana
initiatives at EAPH by following the link:
http://bit.ly/AnalystReportEAPH copy and paste to browser may be
required
About SmallCapStreet.com
SmallCapStreet.com is the leading source for micro-cap and
small-cap stock reports and analysis. We work closely with the very
best Chartered Financial Analysts and financial writers in the
industry to bring accurate and useful information to the investment
community.
For the Stock Profiles Text Keyword "Street" to 25827 to
Receive Instant Mobile Alerts
1. BrokerBank Securities, Inc. is the party responsible for
issuing the press release. Small Cap Street, LLC is the party
responsible for hosting the full analyst report on
SmallCapStreet.com. Marc Bonacci,
Chief Analyst is the author of research report.
2. Information in this release is fact checked and produced on a
best efforts basis and reviewed by Marc
Bonacci, Chief Analyst. However, we are only human and are
prone to make mistakes. If you notice any errors or omissions,
please notify us below.
3. This information is submitted to increase awareness to the
investing public.
4. If you wish to have your company covered in more detail by
our team, or wish to learn more about our services, please contact
us at editor@smallcapstreet.com.
5. For any urgent concerns or inquiries, please contact us
at compliance@smallcapstreet.com.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Marc Bonacci, Chief Analyst. An
outsourced research services provider represented by Marc Bonacci, Chief Analyst, has written and
reviewed the information in this article or report. BrokerBank
Securities, Inc. or Small Cap Street, LLC is not entitled to veto,
interfere or alter the articles, documents or report once created
and reviewed by the outsourced research provider represented by
Marc Bonacci, Chief Analyst.
NOT FINANCIAL ADVICE
BrokerBank Securities, Inc. or Small Cap Street, LLC makes no
warranty, expressed or implied, as to the accuracy or completeness
or fitness for a purpose (investment or otherwise), of the
information provided in this document. This information is not to
be construed as personal financial advice. Readers are encouraged
to consult their personal financial advisor before making any
decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
EAPH has not compensated BrokerBank Securities, Inc. Small Cap
Street, LLC or Marc Bonacci, Chief
Analyst, for the creation or dissemination of this press release.
BrokerBank Securities, Inc. or Small Cap Street, LLC. is not
responsible for any error which may be occasioned at the time of
printing of this document or any error, mistake or shortcoming. No
liability is accepted by BrokerBank Securities, Inc. or Small Cap
Street, LLC. whatsoever for any direct, indirect or consequential
loss arising from the use of this document. BrokerBank Securities,
Inc. or Small Cap Street, LLC. expressly disclaims any fiduciary
responsibility or liability for any consequences, financial or
otherwise arising from any reliance placed on the information in
this document. BrokerBank Securities, Inc. or Small Cap Street,
LLC. does not (1) guarantee the accuracy, timeliness, completeness
or correct sequencing of the information, or (2) warrant any
results from use of the information. The included information is
subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
BrokerBank Securities, Inc. is a member of the Financial
Industry Regulatory Authority, CRD number #130116.
SOURCE BrokerBank Securities, Inc.